Literature DB >> 2162944

Regulation of the neurotensin receptor and intracellular calcium mobilization in HT29 cells.

J T Turner1, M R James-Kracke, J M Camden.   

Abstract

Regulation of the neurotensin receptor-inositol phosphate-intracellular Ca2+ ((Ca2+]i) pathway was studied in HT29 cells. Preincubation with neurotensin or phorbol 12-myristate, 13-acetate decreased the number of cell surface neurotensin receptors and neurotensin-induced increases of inositol trisphosphates and [Ca2+]i. The phorbol 12-myristate, 13-acetate-(43 +/- 1% at 1 microM) but not the neurotensin (65 +/- 9% at 10 nM)-induced decrease in receptors was blocked by staurosporine. The decrease in cell surface receptors was accompanied by a 55 +/- 7% shift of specifically bound 125I-neurotensin from the plasma membrane fraction to the light vesicle fraction of sucrose density gradients if a 37 degrees C incubation step was included. The time course for desensitization of [Ca2+]i mobilization was more rapid (maximal at approximately 1 min) than for loss of receptors (maximal at 45 min). After a 5-min exposure to neurotensin, the cell surface receptor number rapidly returned to control levels in the absence of agonist, but [Ca2+]i sensitivity to neurotensin recovered only partially. Incubation with carbachol, ATP or phorbol 12-myristate, 13-acetate desensitized the subsequent [Ca2+]i response to neurotensin. These results demonstrate a polyphosphoinositide-[Ca2+]i pathway in HT29 cells stimulable by neurotensin and other agents. The results from pre-incubation studies indicate that the neurotensin receptor-signaling pathway is homologously and heterologously regulated. Finally, differences in time courses for loss and recovery of cell surface receptors and desensitization of the [Ca2+]i response, as well as the lack of effect on 125I-neurotensin binding of other agonists that desensitize the neurotensin [Ca2+]i response, suggest that receptor internalization alone does not account for desensitization of the system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162944

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  P2Y2 nucleotide receptor activation up-regulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line.

Authors:  Olga J Baker; Jean M Camden; Danny E Rome; Cheikh I Seye; Gary A Weisman
Journal:  Mol Immunol       Date:  2007-06-27       Impact factor: 4.407

Review 2.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

3.  The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate production.

Authors:  Y Dong; C Q Zeng; J M Ball; M K Estes; A P Morris
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 4.  Neurotensin receptors: binding properties, transduction pathways, and structure.

Authors:  J P Vincent
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

5.  The effect of secretagogues on ion conductances of in vitro perfused, isolated rabbit colonic crypts.

Authors:  E Lohrmann; R Greger
Journal:  Pflugers Arch       Date:  1995-02       Impact factor: 3.657

6.  Role of calcium in carbachol- and neurotensin-induced mucin exocytosis in a human colonic goblet cell line and cross-talk with the cyclic AMP pathway.

Authors:  C Bou-Hanna; B Berthon; L Combettes; M Claret; C L Laboisse
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

7.  Agonist-induced intracellular Ca2+ transients in HT29 cells.

Authors:  R Nitschke; J Leipziger; R Greger
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

8.  Neurotensin expression and release in human colon cancers.

Authors:  B M Evers; J Ishizuka; D H Chung; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969

9.  Neurotensin regulates growth of human pancreatic cancer.

Authors:  J Ishizuka; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

10.  Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

Authors:  D Gully; M Canton; R Boigegrain; F Jeanjean; J C Molimard; M Poncelet; C Gueudet; M Heaulme; R Leyris; A Brouard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.